6/8/2023 | BKHYIG | Moody's assigns Ba3 to Fortrea notes
|
6/1/2023 | BKHYIG | Moody's gives Fortrea, loans Ba3
|
6/1/2023 | BKHYIG | Fitch assigns BB+ to Fortrea, facility
|
5/13/2021 | IG | New Issue: LabCorp details $1 billion senior notes in tranches due 2026, 2031
|
5/12/2021 | IG | New Issue: LabCorp sells $1 billion senior notes in two tranches due 2026, 2031
|
5/12/2021 | CVIG | Moody's assigns LabCorp notes Baa2
|
5/12/2021 | IG | LabCorp to price senior notes in two tranches due 2026, 2031
|
9/9/2020 | SP | New Issue: Credit Suisse sells $596,000 contingent coupon autocallable reverse converts on stocks
|
9/2/2020 | SP | New Issue: Goldman prices $1.2 million leveraged basket-linked notes on 20 stocks
|
7/8/2020 | SP | New Issue: Barclays sells $908,000 trigger autocallable contingent yield notes on Laboratory Corp. of America
|
6/9/2020 | SP | New Issue: JPMorgan prices $625,000 contingent coupon callable yield notes on LapCorp
|
4/24/2020 | SP | New Issue: Goldman prices $1.73 million leveraged basket-linked notes on 19 stocks
|
2/24/2020 | SP | New Issue: CIBC prices $750,000 capped leveraged notes on basket of 50 stocks
|
12/3/2019 | IGLM | LabCorp prices, announces early results of tenders for 4.625% notes
|
12/3/2019 | IGLM | LabCorp gets early tenders for $174.86 million 4.625% notes due 2020
|
11/19/2019 | CVLM | LabCorp to redeem all zero-coupon convertibles due 2021 on Dec. 19
|
11/19/2019 | BKCVIG | Moody’s rates LabCorp. notes Baa2
|
11/18/2019 | EMHYPFPV | Market Commentary: High-grade supply strong; Intel, Dominion Energy, LabCorp, Honda, Western Union, Ameren price
|
11/18/2019 | IG | Market Commentary: High-grade supply strong; Intel, Dominion Energy, LabCorp, Honda, Western Union, Ameren price
|
11/18/2019 | IG | New Issue: Laboratory Corp. of America sells $1.05 billion of senior notes in two tranches
|
11/18/2019 | BKCVIG | S&P rates LabCorp notes BBB
|
11/18/2019 | IG | Market Commentary: Morning Commentary: Western Union, Intel, Dominion Gas, LabCorp, Ameren offer notes
|
11/18/2019 | BK | LabCorp may use proceeds from new note offering for loan repayment
|
11/18/2019 | IGLM | LabCorp begins tender offer for up to $300 million of 4.625% senior notes due 2020
|
11/18/2019 | IG | LabCorp plans to sell dollar fixed-rate senior notes in two parts
|
10/15/2019 | CV | LabCorp says 0% notes due 2021 are convertible for another quarter
|
9/11/2019 | CV | LabCorp 0% convertibles to accrue contingent coupon for six months
|
7/1/2019 | CV | LabCorp says 0% notes due 2021 are convertible for another quarter
|
6/4/2019 | BKIG | S&P rates LabCorp loan BBB
|
6/3/2019 | BK | LabCorp gets new $850 million term loan at Libor plus 80 bps
|
4/1/2019 | CV | LabCorp says 0% notes due 2021 stay convertible for another quarter
|
3/11/2019 | CV | LabCorp 0% convertibles to accrue contingent coupon for six months
|
1/3/2019 | CV | LabCorp says 0% notes due 2021 stay convertible for another quarter
|
9/11/2018 | CV | LabCorp: 0% convertibles accrue contingent coupon for six more months
|
7/2/2018 | CV | LabCorp says 0% notes due 2021 are convertible for another quarter
|
4/2/2018 | CV | LabCorp says 0% notes due 2021 remain convertible through June
|
4/2/2018 | SP | New Issue: CIBC sells $285,000 Raymond James Healthcare Top Selections notes on 16 stocks
|
3/20/2018 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 16 stocks
|
3/20/2018 | SP | CIBC to price notes on 16 Raymond James top pick healthcare stocks
|
3/12/2018 | CV | LabCorp says 0% convertibles accrue coupon for six more months
|
1/2/2018 | CV | LabCorp says 0% notes due 2021 remain convertible through March
|
10/2/2017 | CV | LabCorp says 0% notes due 2021 remain convertible through year-end
|
9/25/2017 | SP | CIBC corrects Cusips for Raymond James Healthcare Top Selections notes
|
9/15/2017 | BK | LabCorp gets $1 billion restated revolver, new $750 million term loan
|
9/11/2017 | CV | LabCorp’s 0% convertibles have contingent coupon for six more months
|
8/18/2017 | EMHYPFPV | Market Commentary: Primary action yields nothing new on Friday after a rather busy week
|
8/18/2017 | IG | Market Commentary: Primary action yields nothing new on Friday after a rather busy week
|
8/18/2017 | IG | Market Commentary: Morning Commentary: High-grade primary action quiet on Friday, ends busy week of issuance
|
8/16/2017 | EMHYPFPV | Market Commentary: LabCorp prices $1.2 billion notes; ComEd sells $1 billion two-part first mortgage bonds
|
8/16/2017 | IG | Market Commentary: LabCorp prices $1.2 billion notes; ComEd sells $1 billion two-part first mortgage bonds
|
8/16/2017 | IG | Market Commentary: Morning Commentary: LabCorp prices notes; Commonwealth Edison plans two-part bond offering
|
8/16/2017 | IG | New Issue: LabCorp details $1.2 billion 3.25% notes due 2024, 3.6% notes due 2027
|
8/15/2017 | IG | New Issue: LabCorp prices $1.2 billion 3.25% notes due 2024, 3.6% notes due 2027
|
8/15/2017 | EMHYPFPV | Market Commentary: Philip Morris, Western Union, Apple, E*Trade price notes; LabCorp plans two-part notes
|
8/15/2017 | IG | Market Commentary: Philip Morris, Western Union, Apple, E*Trade price notes; LabCorp plans two-part notes
|
8/15/2017 | BKCVIG | Moody’s gives Baa2 to LabCorp notes
|
8/15/2017 | BKCVIG | S&P assigns BBB to LabCorp notes
|
8/15/2017 | IG | Market Commentary: Morning Commentary: Philip Morris prices $1.25 billion; LabCorp, Western Union, Apple eye notes
|
8/15/2017 | IG | LabCorp to price fixed-rate notes in two parts via two bookrunners
|
7/31/2017 | BKBWIG | LabCorp to keep leverage post bonds, loans for Chiltern purchase
|
7/26/2017 | SP | New Issue: CIBC sells $443,000 Raymond James Healthcare Top Selections notes tied to 14 stocks
|
7/26/2017 | SP | New Issue: CIBC sells $4.82 million Raymond James Healthcare Top Selections notes on 14 stocks
|
7/20/2017 | SP | CIBC to price notes on 14 Raymond James top pick healthcare stocks
|
7/20/2017 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 14 stocks
|
7/3/2017 | CV | LabCorp says 0% notes due 2021 remain convertible through September
|
4/3/2017 | CV | LabCorp says 0% notes due 2021 remain convertible through June 30
|
3/13/2017 | CV | LabCorp sets contingent cash interest on 0% convertible notes due 2021
|
1/3/2017 | CV | LabCorp says 0% notes due 2021 remain convertible through March
|
10/18/2016 | CVLM | LabCorp’s Sequenom wraps tender offer for convertibles due 2017, 2018
|
10/3/2016 | CV | LabCorp’s 0% notes due 2021 remain convertible through December
|
9/30/2016 | CVLM | LabCorp’s Sequenom takes in tenders for 99.65%, 100% of convertibles
|
9/16/2016 | CVLM | Sequenom begins change-of-control tender offers for 5% convertibles
|
9/12/2016 | CV | LabCorp’s 0% convertibles have contingent coupon for six more months
|
9/7/2016 | CV | LabCorp merger triggers fundamental change under Sequenom convertibles
|
7/1/2016 | CV | LabCorp holders now may convert 0% notes due 2021 through September
|
4/4/2016 | CV | LabCorp’s 0% notes due 2021 can continue to be converted through June
|
3/11/2016 | CV | LabCorp: 0% convertibles accrue contingent coupon for six more months
|
1/4/2016 | CV | LabCorp says 0% notes due 2021 remain convertible through March
|
10/1/2015 | CVLM | LabCorp says 0% notes due 2021 remain convertible until year-end
|
9/11/2015 | CV | LabCorp: 0% convertibles to accrue contingent interest to March 11
|
7/1/2015 | CV | LabCorp says 0% notes due 2021 remain convertible through September
|
4/1/2015 | SPSW | Agents price $1.76 billion in March; BofA prices nearly two-thirds of week’s total volume
|
4/1/2015 | CV | LabCorp’s 0% notes continue to be convertible, now through June
|
3/26/2015 | SP | New Issue: Goldman Sachs prices $60 million equity-linked notes tied to LabCorp
|
3/16/2015 | BK | LabCorp prepays 60-day $400 million bridge loan used for Covance buy
|
3/11/2015 | CV | LabCorp says 0% convertibles to pay contingent interest to Sept. 11
|
3/9/2015 | LMPV | LabCorp: Covance prepays all $250 million notes following acquisition
|
2/19/2015 | BK | LabCorp enters into 60-day $400 million bridge loan for Covance buy
|
1/21/2015 | EMHYMUPFPV | Market Commentary: LabCorp meets huge demand; Kommuninvest, Adobe also price; Adobe tightens in aftermarket
|
1/21/2015 | IG | Market Commentary: LabCorp meets blowout demand; Kommuninvest, Adobe also price; Adobe tightens in aftermarket
|
1/21/2015 | IG | New Issue: LabCorp of America prices $2.9 billion of notes in four tranches
|
1/21/2015 | BKCVIG | Moody’s rates LabCorp notes Baa2
|
1/21/2015 | CVIG | S&P lowers LabCorp, rates notes BBB
|
1/21/2015 | IG | LabCorp talks four-part benchmark notes for Wednesday pricing
|
1/7/2015 | BKCVIG | S&P rates LabCorp loans BBB+
|
1/2/2015 | CV | LabCorp’s zero-coupon notes remain convertible through end of March
|
12/23/2014 | BK | LabCorp enters into $1 billion revolver, $1 billion term loan facility
|